Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-985-9 | CAS number: 92201-55-3 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Cedrus atlantica, Pinaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20-01-2016 to 08-02-2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- in accordance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Cedrus atlantica, ext.
- EC Number:
- 295-985-9
- EC Name:
- Cedrus atlantica, ext.
- Cas Number:
- 92201-55-3
- Molecular formula:
- Not applicable due to UVCB nature of the substance
- IUPAC Name:
- Essential oil of Cedarwood Atlas obtained from the wood of Cedrus atlantica by steam distillation
- Test material form:
- liquid
- Details on test material:
- Name of test material as cited in study report: Cedar atlantica oil
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature
Constituent 1
- Specific details on test material used for the study:
- - pH (1% in water, indicative range): 7.31 - 7.08 (determined by WIL Research Europe)
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 10 weeks old
- Weight at study initiation: body weight variation was within +/-20% of the sex mean.
- Housing: sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG,
Rosenberg, Germany). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United
Kingdom) and shelters (disposable paper corner home, MCORN 404, Datesand Ltd, USA) were
supplied as cage-enrichment. On Day 6, the animals were group housed in Makrolon MII type
cages with a sheet of paper instead of sawdust and cage enrichment.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24 °C
- Humidity (%): relative humidity of 40 to 70%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12- hour light/ 12-hour dark cycle
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Prescreen study: 50 - 100%
Main study: 0 - 10- 25 - 50 % (v/v) - No. of animals per dose:
- 5
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: Increased T-lymphocyte proliferation in the test groups as compared to the concurrent vehicle control group.
EVALUATION
The disintegrations per minute (dpm) value was determined for each test group. This information was used to calculate the Stimulation Index (SI) for each of the test groups (disintegrations per minute of treatment group / disintegrations per minute of control group). A positive response is indicated when one or more test groups shows a SI of 3. The EC3 value is the concentration at which a 3-fold increase of lymph node proliferation is observed. Interpolation is used to determine the EC3 value between two test concentrations (based on the following reference: Basketter DA, Lea LJ, Dickens A, Briggs, D, Pate I, Dearman RJ and Kimber I.A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol 1999; 19:261-266 - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The six monthly reliability check with Hexylcinnamaldehyde, indicates that the Local Lymph Node Assay as performed at WIL Research Europe is an appropriate model for testing for contact hypersensitivity
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- Concentration 0%
- Parameter:
- SI
- Value:
- 5.3
- Test group / Remarks:
- Concentration 10%
- Parameter:
- SI
- Value:
- 5
- Test group / Remarks:
- Concentration 25%
- Parameter:
- SI
- Value:
- 4.5
- Test group / Remarks:
- Concentration 50%
- Parameter:
- other: Mean disintegrations per minute (DPM)/animal
- Value:
- 772
- Test group / Remarks:
- Concentration 0%
- Parameter:
- other: Mean disintegrations per minute (DPM)/animal
- Value:
- 4 096
- Test group / Remarks:
- Concentration 10%
- Parameter:
- other: Mean disintegrations per minute (DPM)/animal
- Value:
- 3 836
- Test group / Remarks:
- Concentration 25%
- Parameter:
- other: Mean disintegrations per minute (DPM)/animal
- Value:
- 3 492
- Test group / Remarks:
- Concentration 50%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
A Stimulation Index (SI) is calculated for each group using the individual SI values. The individual SI is the ratio of the DPM/animal compared to the DPM/vehicle control group mean.
EC3 CALCULATION
The calculated SI values did not show a dose-response relationship and therefore an exact EC3 value could not be calculated. The EC3 value was established to be between >0 and 10%.
CLINICAL OBSERVATIONS:
Systemic Toxicity: No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.
Macroscopic Examination of the Auricular Lymph Nodes and Surrounding Area: All auricular lymph nodes of the animals treated at 10% and control groups were considered normal in size. Most nodes of the animals treated at 25% and 50% were considered enlarged. No macroscopic abnormalities of the surrounding area were noted for any of the animals.
Any other information on results incl. tables
Tables and figures have been included in the attached document "LLNA tables and figures".
Preliminary irritation study:
The results of the epidermal exposures for the selection of highest test substance concentration to be tested in the main study are described in the table (see attachment). Based on signs of systemic toxicity found at 100% (e.g. hunched posture and piloerection were noted for the animals treated at 100% on days 3 and 4, and on the same days very slight erythema was noted for all animals), the highest test item concentration selected for the main study was a 50% concentration.
Main study:
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. The auricular lymph nodes of the control group and animals treated at 10% were considered normal in size however most nodes of the animals treated at 25% and 50% were considered enlarged. Very slight erythema was noted for most animals treated at 50% (Days 2-3) and three animals treated at 25% (Day 3). Scaliness or scabs were noted for most animals treated at 25% and 50% on Day 6.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- The results indicate that the test substance elicits a SI ≥ 3. The EC3 value (the estimated test substance concentration that will give a SI =3) was established to be between >0 and 10%. Under the conditions of this test, Cedarwood Atlas oil needs to be classified for skin sensitization (H317, Skin Sens 1) in accordance with the criteria outlined in Annex I of CLP (1272/2008/EC).
- Executive summary:
The Local Lymph Node Assay (according to OECD 429) was conducted to determine the sensitising potential of Cedar atlantica oil in mice. Lymph node proliferation was determined after exposure to 0%, 10%, 25% or 50% Cedarwood Atlas oil in vehicle, using radioactivity counts (DPM). A pooled approach (per test group) was used. Stimulation indices were calculated.
Measured disintegrations per node (pooled) were 772, 4096, 3836 and 3492 for the 0%, 10%, 25% and 50% dosing groups, respectively. Corresponding stimulation indices (SI) were calculated to be 5.3, 5.0 and 4.5 for the 10%, 20% and 50% concentration, respectively. The EC3 value (the estimated test substance concentration that will give a SI =3) was established to be between >0 and 10%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.